Want to see AMLX full AI Analyst Report?
Amx0035
Wolfram Syndrome
Phase II
Active Not Recruiting
AMX0035 in Adult Patients With Wolfram Syndrome
Dec 22, 2022
―
Amx0035
Amyotrophic Lateral Sclerosis
Phase III
Completed
Extension Study Evaluating The Safety And Tolerability of AMX0035
Oct 27, 2022
―
Amx0035
Alzheimer Disease
Phase II
Completed
Study to Assess the Safety and Biological Activity of AMX0035 for the Treatment of Alzheimer's Disease
Apr 30, 2018
―
Amx0035
Amyotrophic Lateral Sclerosis, Als
Phase II
Completed
Open Label Extension Study of AMX0035 in Patients With ALS
Mar 23, 2018
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Amylyx Pharmaceuticals Inc (AMLX) have in its pipeline
AMLX is currently developing the following drugs: Avexitide, Amx0114, Amx0035. These drug candidates are in various stages of clinical development as the company works toward FDA approval.